Show Nearest IIR Office Phone Number
Off the heels of purchasing Patheon in 2017, Thermo Fisher is acquiring Brammer Bio, a viral vector contract development and manufacturing organization (CDMO) for gene therapy innovators, for $1.7 billion.
(All Fields Required)
